# Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery

Study · id `cardio:ct-nct01361594` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01361594](<https://clinicaltrials.gov/study/NCT01361594>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01361594

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 338 participants.

## Technical summary

Registry record NCT01361594. Randomized; no masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2013-12 (actual). Results posted on 2014-12-31.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 338 participants (enrolled count; ClinicalTrials.gov record NCT01361594, source copy `cardio:ctgov-nct01361594-2014-12-31`, retrieved 2026-10-26)
- Start date: 2011-06 (registry gives no type) (ClinicalTrials.gov record NCT01361594, source copy `cardio:ctgov-nct01361594-2014-12-31`, retrieved 2026-10-26)
- Primary completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01361594, source copy `cardio:ctgov-nct01361594-2014-12-31`, retrieved 2026-10-26)
- Completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01361594, source copy `cardio:ctgov-nct01361594-2014-12-31`, retrieved 2026-10-26)
- Results first posted: 2014-12-31 (ClinicalTrials.gov record NCT01361594, source copy `cardio:ctgov-nct01361594-2014-12-31`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01361594, source copy `cardio:ctgov-nct01361594-2014-12-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01361594-2014-12-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery
- Acronym: CABG
- Condition: Diabetes
- Intervention (Other): Regular insulin (intensive treatment)
- Intervention (Other): Regular Insulin (conventional treatment)
- Lead sponsor: Emory University
- Lead sponsor class: OTHER
- Collaborator: American Diabetes Association
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Emory University (`cardio:org-emory-university`)
- Registry lists this organization as a collaborator: American Diabetes Association (`cardio:ada`)

## Provenance

Content hash: e19c62d8b5a60683d9e7467f49cb4ed57f2a0dcc3135ceb2386655c6834f1860
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
